Boryung Pharmaceutical

Korean pharma, cardiovascular fixed-dose combinations

003850 · KOSPI · South Korea

Public Market Listing

003850KOSPI

KOSPI primary exchange listing

Live quotes, historical charts, and market capitalization for Boryung Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Phase 3
AT1 receptor; NPC1L1; HMG-CoA reductaseSmall molecule
HypertensionAtherosclerotic Cardiovascular Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Quarterly & interim (1)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2026-Q1——$170M—report ↗

Annual history (5 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$716M—$158M—report ↗

Boryung Pharmaceutical reported revenue of $716.05M, down 4.2% YoY and cash and equivalents of $157.61M for fiscal year 2025.

Figures only: this period's report disclosed no narrative text

View 4 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$747M$38M$128M—report ↗
2023-FY$659M$36M$13M—report ↗
2022-FY$591M$32M——report ↗
2021-FY$520M$34M——report ↗